John C. Martin, PhD

Chairman and Chief Executive Officer, Gilead Sciences

Dr. Martin joined Gilead Sciences in 1990 and currently serves as Chairman of the Gilead Sciences Board of Directors and Chief Executive Officer. He served as President and Chief Executive Officer from 1996 through May 2008. Prior to joining Gilead, Dr. Martin held several leadership positions in the antiviral chemistry division at Bristol-Myers Squibb and served for six years with Syntex Corporation, from 1978 until 1984.

Dr. Martin is a member of the Presidential Advisory Council on HIV/AIDS, the Board of Directors of Gen-Probe Incorporated and the Board of Directors of the California Healthcare Institute (Chair, 2005-2006). He also served as President of the International Society for Antiviral Research from 1998-2000.